Singapore markets closed

Larimar Therapeutics, Inc. (LRMR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.25+0.12 (+1.48%)
As of 11:20AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4443
Avg. Estimate-0.23-0.28-1.23-2.1
Low estimate-0.25-0.3-1.3-2.4
High estimate-0.21-0.25-1.17-1.87
Year ago EPS-0.15-0.19-0.84-1.23
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3343
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.25-0.19-0.22-0.25
Actual EPS-0.15-0.19-0.21-0.3
Difference0.100.01-0.05
Surprise %40.00%0.00%4.50%-20.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.23-0.28-1.23-2.1
7 days ago-0.23-0.28-1.23-2.1
30 days ago-0.23-0.28-1.23-2.1
60 days ago-0.28-0.35-1.47-1.7
90 days ago-0.25-0.26-1.05-1.28
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLRMRIndustrySector(s)S&P 500
Current qtr.-53.30%N/AN/AN/A
Next qtr.-47.40%N/AN/AN/A
Current year-46.40%N/AN/AN/A
Next year-70.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A